- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06542666
Cognitive Functional Therapy for Chronic Shoulder Pain: Pilot and Feasibility Study
Cognitive Functional Therapy Versus Therapeutic Exercises for Treating Individuals With Chronic Shoulder Pain: A Pilot and Feasibility Study
This pilot randomized controlled clinical trial (RCT) will assess the feasibility and identify the key components necessary for conducting the main RCT, which will involve the comparison of Cognitive Functional Therapy with Therapeutic Exercises in individuals with chronic shoulder pain. The main questions it aims to answer are:
- What barriers to the participation of the included individuals might arise?
- Will the assessment procedures and outcome measures be feasible and suitable?
- What time will be necessary to conduct the assessments?
- Will participants be willing to be randomized to the proposed treatment groups?
- What barriers to the clinical delivery of Cognitive Functional Therapy in the healthcare system might exist?
- Will the treatment(s) be acceptable to patients?
- Will participants adhere to the treatment?
- What will the recruitment rates be per week/month?
- Will there be any selection bias?
- Will participant retention be high among the allocation groups?
- Will the data be complete?
- What will the data variability be?
- Will the treatment effects/outcomes be consistent with expectations and previous literature?
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: VALÉRIA MA OLIVEIRA, PhD
- Phone Number: 7183 55 83 32167200
- Email: valeria.mayaly@gmail.com
Study Locations
-
-
Paraíba
-
João Pessoa, Paraíba, Brazil, 58051-970
- Recruiting
- Federal University of Paraíba
-
Contact:
- VALÉRIA MA OLIVEIRA, PhD
-
Principal Investigator:
- VALÉRIA MA OLIVEIRA, PhD
-
Principal Investigator:
- RAQUEL MC DINIZ, PT
-
Principal Investigator:
- JÉSSICA MS EUGÊNIO, PT
-
Principal Investigator:
- DANILO H KAMONSEKI, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Men and women;
- Age between 18 and 60 years;
- Presence of shoulder pain for more than 3 months;
- Pain intensity of 4 points or more on the 11-point Numeric Pain Rating Scale during the past week.
- High level of disability or moderate level of irritability.
Exclusion Criteria:
- History of fracture or surgery of the clavicle, scapula, and/or humerus, surgical stabilization or rotator cuff repair;
- History of dislocation, instability (positive sulcus sign or apprehension test), and/or rotator cuff tear (positive drop arm test);
- Adhesive capsulitis verified by the presence of gradual onset pain associated with stiffness and reduced passive and active mobility;
- Ongoing pregnancy;
- Reproduction of shoulder pain radiating to the entire upper limb during cervical or thoracic spine tests (positive Spurling test);
- Neurological or systemic diseases that may alter muscle strength and sensitivity such as rheumatoid arthritis, fibromyalgia, lupus, gout, and diabetes;
- Corticosteroid injection in the shoulder region in the last 3 months;
- Physiotherapy treatment in the last 6 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Functional Therapy
Cognitive Functional Therapy will be conducted once a week, in individual and in-person sessions lasting approximately 40 minutes, over eight weeks.
|
The intervention focuses on addressing the maladaptive cognitive, physical, and lifestyle behaviors related to the disorder. Cognitive functional therapy will focus on factors considered to contribute to the pain disorder, addressing the following topics:
|
|
Active Comparator: Exercises
Twelve participants will be allocated to this group.
They will perform strengthening and stretching exercises twice a week for eight weeks, with each session lasting approximately 30 to 40 minutes.
|
Individuals allocated to this group will perform stretching and strengthening exercises. The self-stretching exercises will target the upper trapezius and posterior shoulder region. Each stretching exercise will be performed for 3 repetitions of 30 seconds, with an interval of 10 seconds between repetitions. The strengthening exercises will be performed using resistance elastic bands. Three sets of 10 repetitions will be performed for each strengthening exercise, with 1 minute of rest between sets. The strengthening exercises will target the lower and middle trapezius, anterior serratus, and the external and internal rotators of the shoulder. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment rate
Time Frame: 8 weeks
|
Analyze the ability to recruit 12 individuals per group, totaling a sample of 24 individuals with chronic shoulder pain;
|
8 weeks
|
|
Retention rate
Time Frame: 8 weeks
|
This will be evaluated through individual follow-up by the responsible physiotherapist during the 8-week treatment period, during which the physiotherapist will fill out an attendance sheet at each session to also characterize the completion of the intervention by each participant;
|
8 weeks
|
|
Acceptability of the intervention
Time Frame: 8 weeks
|
This will be estimated through adherence to the appointment schedule and mainly through questioning after each intervention session.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
The pain will be measured with 11 point - Numerical Rating Pain Scale with scores ranging from 0 (no pain) to 10 (maximum pain).
|
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
|
Shoulder Pain and Disability Index
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
Shoulder disability will be measured with Shoulder Pain and Disability Index (SPADI), with score ranging from 0 to 100, with higher scores indicating greater shoulder disability.
|
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
|
Chronic Pain Self-Efficacy Scale
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
Self-efficacy will be measured using the Chronic Pain Self-Efficacy Scale (CPSS).
The total score ranges from 30 to 300 points, with higher scores indicating greater self-efficacy.
|
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
|
Tampa Scale for Kinesiophobia
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
Kinesiophobia will be measured using the Tampa Scale for Kinesiophobia (TSK).
The total score ranges from 17 to 68 points, with higher scores indicating worse beliefs about pain related to movement.
|
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
|
Pain Catastrophizing Scale
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
Pain catastrophizing will be measured using the Pain Catastrophizing Scale (PCS).
The total score ranges from 0 to 52 points, with higher scores indicating greater pain catastrophizing.
|
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
|
Pittsburgh Sleep Quality Index
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI).
The total score ranges from 0 to 21 points.
A score greater than 5 indicates poor sleep quality, with significant difficulty in at least two components of the questionnaire or moderate difficulty in three components.
|
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
|
Biopsychosocial aspects
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
Biopsychosocial aspects will be measured with short screening questions on biopsychosocial aspects of chronic pain.
|
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
|
Patients' expectations of the treatment.
Time Frame: Baseline
|
For the assessment of patients' expectations regarding their treatment, participants will respond to the question, "How much do you expect your shoulder problem to change as a result of treatment?"
Their responses will be measured on a 7-point Likert scale, where 1 corresponds to "worse" and 7 corresponds to "completely recovered."
|
Baseline
|
|
Patient-Specific Functional Scale
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
The Patient-Specific Functional Scale (PSFS) will be used to assess functional status.
Individuals will score on an 11-point scale, indicating how difficult it is to perform 3 to 5 activities that are important to them.
A score of 0 on the 11-point scale indicates "unable to perform the activity," while a score of 10 indicates "able to perform the activity at the pre-injury level.
|
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: VALÉRIA MA OLIVEIRA, PhD, Universidade Federal da Paraíba
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 79422824.0.0000.5188
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.